Management & Advisors
Management
Dr. Ernst Böhnlein Chief Executive Officer
Dr. Sabine Freundlieb Management Scientific Affairs
 
TET Committee
Makes decisions regarding the Licensing Strategy for the Tet Technology IP.
TET Committee members are:
Professor Dr. Hermann Bujard  
Dr. Werner Henrich former Head of Global IP and Licensing, Hoffmann-La Roche

Suzanne A. Lebold, PhD

Divisional Vice President
Scientific Assessment and Technology Licensing
Global Pharmaceutical Licensing and New Business Development
Abbott Bioresearch

 
Supervisory Board
Professor Dr. Hermann Bujard Chairman
Dr. Werner Henrich former Head of Global IP and Licensing, Hoffmann-La Roche
Dr. Wolfgang Witz Lawyer, Partner Allen & Overy